Association of the inflammatory burden index with 1-year major adverse cardiovascular events in patients with HFpEF after myocardial infarction: a single-center retrospective cohort study - Scorecard - MDSpire

Association of the inflammatory burden index with 1-year major adverse cardiovascular events in patients with HFpEF after myocardial infarction: a single-center retrospective cohort study

  • By

  • Xiaoyan Yin

  • Pan Chen

  • Boshi Liu

  • Lei Ren

  • June 10, 2026

  • 0 min

Share

Clinical Scorecard: Link Between Inflammatory Burden Index and One-Year Major Adverse Cardiovascular Events in HFpEF Patients Following Myocardial Infarction: A Retrospective Cohort Analysis from a Single Center

At a Glance

CategoryDetail
ConditionHeart Failure with Preserved Ejection Fraction (HFpEF) following Myocardial Infarction (MI)
Key MechanismsInflammatory activation contributing to adverse remodeling and cardiovascular events
Target PopulationPatients with HFpEF and documented MI
Care SettingSingle-center, retrospective cohort study

Key Highlights

  • Higher logIBI associated with 1-year major adverse cardiovascular events (MACE)
  • 74 patients (12.5%) experienced MACE during follow-up
  • LogIBI improved risk discrimination in predicting MACE
  • C-index increased from 0.776 to 0.817 with logIBI addition
  • Decision curve analysis indicated higher net benefit with logIBI

Guideline-Based Recommendations

Diagnosis

  • HFpEF defined as symptomatic heart failure with LVEF ≥ 50%
  • MI identified according to contemporary clinical records

Management

  • Consider inflammatory markers like IBI in risk assessment post-MI

Monitoring & Follow-up

  • Follow-up for 1 year through outpatient records and electronic medical records

Risks

  • Patients with higher logIBI face increased risk of MACE

Patient & Prescribing Data

592 patients with HFpEF and documented MI

Inflammatory markers may guide management strategies

Clinical Best Practices

  • Integrate IBI in clinical assessments for HFpEF post-MI
  • Monitor inflammatory markers for risk stratification

Related Resources & Content

Original Source(s)

Related Content